News About: Pharm. Industry
KFDA likely to approve China’s new flu vaccine in October
Boryung BioPharma said that China’s first home-grown H1N1 flu vaccine, which producer Sinovac Biotech Ltd. (NYSE Amex: SVA) says is effective after only one dose, will be approved in this October at the latest, as Kor...
Boryung BioPharma to produce flu vaccines
Boryung BioPharma will become another influenza vaccine producer with the establishment of its flu vaccine factory, according to a company spokesman.
The company held its factory completion ceremony on September 7 ...
New medicine Toviaz launched for overactive bladder
Pfizer Korea said it has released a new prescription drug called Toviaz (fesoterodine fumarate) to treat overactive bladder (OAB) in adults.
Toviaz, which is taken once daily, is available as an extended-release ta...
Number of chronic renal failure patients more than doubled in 8 years
Due to multiplying senior population and diets high in salt, the number of patients suffering chronic renal failure (CRF) has more than doubled between 2001 to 2008, showed a report released by the National Health Ins...
KPMA to assess possible damage of price cut
The Korea Pharmaceutical Manufacturers Association has unveiled its plan to assess the possible damage that the government’s drug price cut policy would cause in the local pharmaceutical industry.
To this end, the ...
Dong-A overtakes Sanofi-Aventis Korea
Dong-A Pharm retook the number one spot in the local prescription drug market, industry data showed recently.
According to IMS data, Dong-A’s second-quarter ethical sales came in at 107.7 billion won, beating that ...
Trade deficit declines in pharmaceutical products
Korea’s trade deficit in drug related businesses is showing a downward trend in the first half of this year due to sluggish demand for imported raw materials, a local organization said on August 27.
According to th...
Boehringer Ingelheim Korea releases Antistax leg vein health capsule
Boehringer Ingelheim Korea said it has launched Antistaxⓡ, a natural food supplement which can help maintain leg vein health.
Antistax comes in small, easy to swallow red capsules containing a unique extract of red...
Growing demand over Relenza
Due to growing concerns over the rapidly spreading H1N1 flu virus, many pharmacies are making efforts to secure a sufficient supply of treatment drugs, including GlaxoSmithKline’s antiviral drug Relenza, for their sto...
Government urged to scrap low-priced incentive system
Pharmaceutical firms and wholesalers have rolled up their sleeves to stop the controversial low-priced incentive system.
The incentive system means that when a medical institution purchases a drug whose price is lo...
